TCON TRACON Pharmaceuticals, Inc. Net Sales Margin

TRACON Pharmaceuticals, Inc. - graphic logo of issuer TCON

TRACON Pharmaceuticals develops targeted antibodies to combat tumors by blocking the nutrient supply to cancer cells. The GURU.Markets system highlights this level of commercial profitability, where 0.00 characterizes this valuation parameter. Growth is supported by cloud-based automation of biodata processing and a strategy to secure partners among pharma behemoths to fill the shortage of effective oncology therapies.

TRACON Pharmaceuticals, Inc (TCON) - Return on Sales by Net Profit from 07/04/2022 to 08/04/2024

TCON (TRACON Pharmaceuticals): analytical breakdowns and indicator data

- market value and analyst target forecast:
Fundamental company valuation:TRACON Pharmaceuticals Inc. - TCON
Finished products of TRACON Pharmaceuticals, Inc

Net profit margin measures the ultimate efficiency of a business by determining the portion of profit in every dollar earned. This metric is calculated as the ratio of net income to revenue, demonstrating sensitivity to operating expenses. By analyzing the integral net margin indicator, an investor can observe capitalization dynamics and the risks of overpayment. For TRACON Pharmaceuticals (TCON), the absence of cyclical demand for oncology drugs stabilizes this indicator, although dependence on liquidity may cause sharp fluctuations in margins.

Competitors of TRACON Pharmaceuticals (TCON)

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|MGX: Return on Sales by Net Profit|Net Margin Precision BioSciences|GBIO (generationbio.com) - Return on Sales by Net Profit|Net Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Net Sales Margin|Net Return on Sales IMNN (Imunon, Inc.)|Net Sales Margin PHIO|MBIO - Net Margin|Net Sales Margin RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Net Margin|Applied DNA - Net Sales Margin|Net Margin Bluebird Bio|ImmunoPrecise (IPA) - Net Margin|Net Profit Margin OMGA (Omega)|Net Margin Singular Genomics Systems|Net Margin regulusrx.com RGLS|Net Margin Syros Pharmaceuticals Inc. (SYRS)|Company Sales Margin Codex DNA|Net Margin Unity Bio UBX